Litchibot
Litchibot develops physical-AI infrastructure that lets robot skills transfer across hardware.
UndisclosedSeed
ParticipantActivity from announced rounds
GL Ventures is the Hillhouse-origin early-stage venture firm identified in LTZ and Clipto issuer announcements.
LTZ develops cancer immunotherapies targeting myeloid biology. Clipto supplies tools for searching video and audio libraries, while Anew combines AI models and experiments for drug discovery. These histories remain distinct from the Hillhouse parent and named funds.
Litchibot develops physical-AI infrastructure that lets robot skills transfer across hardware.